[Vertical transmission of HTLV-1 in Peru].

Transmisión vertical de HTLV-1 en el Perú

Publisher: Instituto Nacional de Salud Country of Publication: Peru NLM ID: 101227566 Publication Model: Print Cited Medium: Internet ISSN: 1726-4642 (Electronic) Linking ISSN: 17264634 NLM ISO Abbreviation: Rev Peru Med Exp Salud Publica Subsets: MEDLINE

Original Publication: Lima : Instituto Nacional de Salud

Endemic Diseases* ; Infectious Disease Transmission, Vertical*; HTLV-I Infections/*epidemiology ; HTLV-I Infections/*transmission; Humans ; Peru

Human type 1 T-cell lymphotropic virus (HTLV-1) infection has been described in many areas of the world, including Caribbean countries, Japan, Africa, Oceania and South America. In this review we define the endemicity of HTLV-1 in the country proposing four epidemiological criteria. Then we discuss the core subject of the review, which is the vertical transmission of HTLV-1. This mechanism is one of the main forms of transmission in our country. Within the development of this particular topic, we present an estimated rate of vertical transmission and the risk factors associated to vertical transmission based on an exhaustive review of the national and international literature. This review pretend to provide a first approach to the vertical transmission of HTLV-1, an aspect poorly studied in our country.

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):604-9. (PMID: 16773029)
Am J Trop Med Hyg. 1997 May;56(5):561-5. (PMID: 9180608)
Rev Panam Salud Publica. 2010 May;27(5):330-7. (PMID: 20602066)
Infect Dis Clin North Am. 2000 Mar;14(1):211-39, x-xi. (PMID: 10738680)
J Med Microbiol. 2006 Jun;55(Pt 6):765-770. (PMID: 16687597)
Sex Transm Infect. 2000 Oct;76(5):366-70. (PMID: 11141853)
J Pediatr. 2009 Nov;155(5):700-6. (PMID: 19628219)
J Infect Dis. 2004 Oct 1;190(7):1275-8. (PMID: 15346338)
J Reprod Immunol. 2000 Jul;47(2):197-206. (PMID: 10924751)
Braz J Infect Dis. 1998 Jun;2(3):135-142. (PMID: 11103001)
Clin Microbiol Rev. 2010 Jul;23(3):577-89. (PMID: 20610824)
Rev Soc Bras Med Trop. 2009 Jan-Feb;42(1):28-32. (PMID: 19287932)
Rev Inst Med Trop Sao Paulo. 2009 Jan-Feb;51(1):25-9. (PMID: 19229387)
J Gynecol Obstet Biol Reprod (Paris). 2004 Feb;33(1 Pt 1):14-20. (PMID: 14968050)
J Health Popul Nutr. 2002 Mar;20(1):51-8. (PMID: 12022160)
J Hum Virol. 1997 Nov-Dec;1(1):37-44. (PMID: 10195229)
Am J Trop Med Hyg. 2004 Feb;70(2):158-63. (PMID: 14993627)
BMJ. 2000 Jun 3;320(7248):1497-501. (PMID: 10834889)
Clin Infect Dis. 2004 Oct 1;39(7):939-44. (PMID: 15472843)
Rev Inst Med Trop Sao Paulo. 2002 Mar-Apr;44(2):63-5. (PMID: 12048541)
Arch Intern Med. 1992 Jul;152(7):1429-32. (PMID: 1352675)
AIDS Rev. 2009 Oct-Dec;11(4):205-14. (PMID: 19940947)
J Med Virol. 1992 Sep;38(1):44-8. (PMID: 1402830)
J Med Virol. 1999 Dec;59(4):541-6. (PMID: 10534739)
J Infect Dis. 1994 Apr;169(4):754-9. (PMID: 8133088)
Clin Infect Dis. 2004 Oct 1;39(7):1079-82. (PMID: 15472866)
Oncogene. 2005 Sep 5;24(39):6058-68. (PMID: 16155612)
Int J Cancer. 1999 Sep 9;82(6):832-6. (PMID: 10446450)
J Immunol. 2001 Mar 15;166(6):4231-6. (PMID: 11238676)
J Infect Dis. 2005 May 1;191(9):1490-7. (PMID: 15809908)
J Biomed Sci. 2002 Nov-Dec;9(6 Pt 2):587-95. (PMID: 12432224)
Int J Infect Dis. 2003 Jun;7(2):132-7. (PMID: 12839715)
J Med Virol. 2004 Oct;74(2):207-15. (PMID: 15332268)
J Med Virol. 2007 Dec;79(12):1974-8. (PMID: 17935192)
Clin Infect Dis. 2002 Jun 15;34(12):1551-7. (PMID: 12032888)
Rev Panam Salud Publica. 2007 Oct;22(4):223-30. (PMID: 18078583)
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):104-9. (PMID: 15608533)

R01 NS055627 United States NS NINDS NIH HHS; R03 TW007819 United States TW FIC NIH HHS; R24 TW007988 United States TW FIC NIH HHS

Date Created: 20110504 Date Completed: 20110901 Latest Revision: 20211020

20240829

PMC3509803

10.1590/s1726-46342011000100016

21537777